Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
115
- +12 vs. Q1 2026
- Total value $65.7M
Superinvestors holding LUCD
0
- None of the superinvestors held LUCD at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by LUCD insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | May 20, 2026 | Matheis DennisDirector | PPurchaseCommon Stock | +245K | $1.00 | +$245K | 1.03M | +31.1% | SEC |
| Aug 22, 2025 | Aug 20, 2025 | Matheis DennisDirector | PPurchaseCommon Stock | +100K | $1.02 | +$102K | 665.44K | +17.7% | SEC |
| May 23, 2025Amended | May 20 – May 22, 2025 | Matheis DennisDirector | PPurchaseCommon Stock | +350K | $1.3093 | +$458.26K | 565.44K | +162.5% | SEC |
| Sep 27, 2023 | Sep 25 – Sep 26, 2023 | Lapidus StanleyDirector | SSaleCommon stock | −29.95K | $1.4499 | −$43.42K | 101.59K | −22.8% | SEC10b5-1 |
| Sep 27, 2023Amended | Sep 20 – Sep 21, 2023 | Lapidus StanleyDirector | SSaleCommon stock | −3.92K | $1.4487 | −$5.67K | 131.54K | −2.9% | SEC10b5-1 |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in LUCD at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 8,856,844 | $9.48M | 0.02% | +8,856,844 | New |
| BlackRock, Inc. | 8,373,117 | $8.96M | 0.00% | +3,734,874+80.5% | Added |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,556,344 | $7.02M | 0.00% | +2,401,574+57.8% | Added |
| Two Seas Capital LP | 6,000,000 | $6.42M | 0.25% | +3,000,000+100.0% | Added |
| MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $4.28M | 0.60% | 00.0% | Unchanged |